pubmed.ncbi.nlm.nih.gov

Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression - PubMed

  • ️Sun Jan 01 2006

Review

. 2006 Oct 30;25(51):6817-30.

doi: 10.1038/sj.onc.1209942.

Affiliations

Review

Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression

D S Bassères et al. Oncogene. 2006.

Abstract

Abundant data support a key role for the transcription factor nuclear factor-kappaB (NF-kappaB) signaling pathway in controlling the initiation and progression of human cancer. NF-kappaB and associated regulatory proteins such as IkappaB kinase (IKK) are activated downstream of many oncoproteins and there is much evidence for the activation of NF-kappaB-dependent target genes in a variety of solid tumors and hematologic malignancies. This review focuses on the mechanisms by which the NF-kappaB pathway is activated in cancer and on the oncogenic functions controlled by activated NF-kappaB. Additionally, the effects of NF-kappaB activation in tumors relative to cancer therapy are also discussed.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources